NCT02681640View on ClinicalTrials.gov

uPAR PET/CT for Preoperative Staging of Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 10, 2017

Study Completion Date

March 31, 2017

Conditions
Breast Cancer
Interventions
OTHER

68Ga-NOTA-AE105

One injection of 68Ga-NOTA-AE105

DEVICE

Positron Emission Tomography PET/CT

Following injection of 68Ga-NOTA-AE105 the patients will be subjected to Positron Emission Tomography PET/CT

Trial Locations (1)

2100

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen

Sponsors

Collaborators (1)

Curasight ApS
All Listed Sponsors
collaborator

Curasight ApS

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT02681640 - uPAR PET/CT for Preoperative Staging of Breast Cancer Patients | Biotech Hunter | Biotech Hunter